Log in
Enquire now
Neurimmune AG

Neurimmune AG

Neurimmune AG is a Schlieren, Zurich-based pharmaceutical company

OverviewStructured DataIssuesContributors

Contents

neurimmune.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Technology
Technology
Biopharmaceutical
Biopharmaceutical
Biotechnology
Biotechnology
Biomedical engineering
Biomedical engineering
Synthetic biology
Synthetic biology
Therapeutics
Therapeutics
Consumer biotechnology
Consumer biotechnology
...
Location
Switzerland
Switzerland
Schlieren, Switzerland
Schlieren, Switzerland
0
B2X
B2B
B2B
CEO
Roger M Nitsch
Roger M Nitsch
0
Founder
‌
Jan Grimm
Legal Name
Neuroimmune AG
Legal classification
Aktiengesellschaft
Aktiengesellschaft
Public limited company
Public limited company
Date Incorporated
2017
Number of Employees (Ranges)
51 – 200
Email Address
Phone Number
Full Address
Wagistrasse 18, 10th floor 8952 Schlieren / Zurich Switzerland0
Investors
‌
Biogen Idec
Founded Date
November 14, 2006
Total Funding Amount (USD)
150,000,000
Latest Funding Round Date
October 25, 2017
Latest Funding Type
‌
Venture round
Country
Switzerland
Switzerland
0

Other attributes

Company Operating Status
Active

Neurimmune AG is a biopharmaceutical company developing human immune memory into antibody therapeutics, with a focus on discovering cures for Alzheimer's disease.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Neurimmune AG

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us

Explore companies

  • Artificial Intelligence
  • Fintech
  • Biotechnology
  • Cybersecurity
  • Semiconductors
  • Electric Vehicles
  • Cloud Computing
  • Robotics
  • SaaS
  • Renewable Energy
  • Venture Capital
  • Blockchain
  • Browse all →
By using this site, you agree to our Terms of Service.